Nancy Laurens
About Nancy Laurens
Nancy Laurens is the Disease Area Head Immuno-Oncology at Bristol Myers Squibb with over 15 years of experience in oncology, including roles in medical affairs and clinical research.
Current Position at Bristol Myers Squibb
Nancy Laurens currently serves as the Disease Area Head of Immuno-Oncology at Bristol Myers Squibb. This role involves leading key initiatives and strategies within the immuno-oncology domain, reflecting her extensive background in medical science and oncology.
Leadership Experience in Immuno-Oncology
Since August 2020, Nancy Laurens has been leading the medical affairs team in Immuno-Oncology at Bristol Myers Squibb. Her leadership underscores her expertise and capabilities in managing complex medical projects and driving advancements in cancer treatment.
Previous Roles at Bristol Myers Squibb
Nancy Laurens has a history of roles at Bristol Myers Squibb. From 2017 to 2020, she served as the Manager of Medical Science Managers Immuno-Oncology in Utrecht en omgeving, Nederland. Before that, she was a Scientific Advisor Oncology from 2015 to 2017, playing a vital role in the company’s oncology research and development efforts.
Past Experience in Oncology and Medical Affairs
Nancy Laurens has over 15 years of experience in the oncology field. She held the position of Medical Affairs Manager Oncology at Merck Sharp & Dohme from 2011 to 2014, and before that, she was a Regional Medical Liaison Oncology at Amgen from 2010 to 2011. Her extensive experience spans various roles, including project management and clinical research.
Clinical Research Background
Nancy Laurens has a strong clinical research background. She served as a Clinical Research Associate (CRA) at Merck, Sharpe & Dohme from 2007 to 2009 and at NDDO Oncology from 2005 to 2007. Her experience in clinical research has significantly contributed to her expertise in oncology treatment and research.
Academic Background and PhD
Nancy Laurens completed her PhD focusing on oncology research at Vrije Universiteit Amsterdam and TNO Quality of Life between 2000 and 2005. Prior to her doctorate, she studied at Vrije Universiteit Amsterdam from 1995 to 2000. Her academic endeavors have laid a strong foundation for her career in medical science and oncology.